Streetbeat News

Regulatory

GSK

A correction was issued regarding the news about GSK's FDA Breakthrough Therapy designation, which was initially reported on August 20.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 6:12 pm

ACB

CGC

CRON

CURLF

MJ

MSOS

OGI

SNDL

TLRY

Cannabis stocks are experiencing a decline following the DEA's announcement to delay its final ruling on cannabis rescheduling until after the November presidential election.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 6:11 pm

BTCUSD

ETHUSD

Veteran Bitcoin investor Lark Davis predicts a significant bull run for Bitcoin and the crypto market in the next 12 months, citing high gold prices and a weakening dollar as bullish indicators. J.P. Morgan forecasts gold prices to rise further, and the U.S. elections could bring a pro-crypto president.

Portfolio Pulse from Khyathi Dalal

August 27, 2024 | 6:06 pm

GSK

GSK has received the US FDA Breakthrough Therapy Designation for its B7-H3-targeted antibody-drug conjugate, aimed at treating relapsed or refractory extensive-stage small-cell lung cancer. This designation could expedite the development and review process of the drug.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 6:05 pm

EIS

SPY

The White House, through spokesperson John Kirby, has issued a warning to Iran against initiating a regional war. The U.S. has affirmed its commitment to defend Israel if attacked and remains hopeful about ongoing Gaza ceasefire talks, with all parties engaged.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 6:03 pm

PMN

ProMIS Neurosciences has been granted a US patent for methods of reducing toxicity induced by amyloid beta oligomers using specific antibodies in Alzheimer's treatment. This patent could enhance their position in the Alzheimer's treatment market.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 6:02 pm

SPY

The Federal Reserve's discount rate meeting minutes reveal that directors from the Chicago and New York Federal Reserve banks favored a cut in the discount rate. This indicates a potential shift in monetary policy, which could impact market sentiment and stock prices.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 6:01 pm

NICK

Nicholas Financial has received a notification from Nasdaq regarding noncompliance with Listing Rule 5250(c)(1), which pertains to timely filing of periodic financial reports. This could impact the company's stock listing status.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 5:41 pm

LLY

Senator Bernie Sanders is urging Eli Lilly to reduce the costs of its weight loss drugs. This move could impact Eli Lilly's pricing strategy and market position in the pharmaceutical industry.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 5:32 pm

NDAQ

Nasdaq has filed with the SEC to list and trade Bitcoin Index Options, following NYSE's similar plans. This move aims to expand cryptocurrency offerings and reflects growing interest from traditional financial institutions in digital assets. Regulatory approval is pending.

Portfolio Pulse from Murtuza Merchant

August 27, 2024 | 5:31 pm